This article was initially published on the Journal of Breast Cancer with a misspelled the abbreviation in figure 3. The abbreviation ‘HP’ should be corrected as ‘HR’.
. 2020 Mar 5;23(2):230–231. doi: 10.4048/jbc.2020.23.e19
Erratum: Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer
Chuqian Lei
1,2, Ciqiu Yang
1, Bin Xia
3,4, Fei Ji
1, Yi Zhang
1, Hongfei Gao
1, Qianqian Xiong
5, Yufeng Lin
6, Xiaosheng Zhuang
1,7, Liulu Zhang
1, Teng Zhu
1, Minyi Cheng
1, Mei Yang
1, Kun Wang
1,2
Chuqian Lei
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
2The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Find articles by Chuqian Lei
Ciqiu Yang
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Find articles by Ciqiu Yang
Bin Xia
3Clinical Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
4Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
Find articles by Bin Xia
Fei Ji
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Find articles by Fei Ji
Yi Zhang
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Find articles by Yi Zhang
Hongfei Gao
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Find articles by Hongfei Gao
Qianqian Xiong
5Department of General Surgery, Shenzhen Tradition Chinese Medicine Hospital, Shenzhen, China.
Find articles by Qianqian Xiong
Yufeng Lin
6Department of General Surgery, Zhuhai Golden Bay Center Hospital, Zhuhai, China.
Find articles by Yufeng Lin
Xiaosheng Zhuang
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
7Shantou University Medical College, Shantou, China.
Find articles by Xiaosheng Zhuang
Liulu Zhang
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Find articles by Liulu Zhang
Teng Zhu
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Find articles by Teng Zhu
Minyi Cheng
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Find articles by Minyi Cheng
Mei Yang
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Find articles by Mei Yang
Kun Wang
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
2The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Find articles by Kun Wang
1Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
2The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
3Clinical Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
4Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
5Department of General Surgery, Shenzhen Tradition Chinese Medicine Hospital, Shenzhen, China.
6Department of General Surgery, Zhuhai Golden Bay Center Hospital, Zhuhai, China.
7Shantou University Medical College, Shantou, China.
Collection date 2020 Apr.
© 2020 Korean Breast Cancer Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC7192745 PMID: 32395382
This corrects the article "Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer" on page 47.